Blood cancer treatment varies dramatically by subtype—acute myeloid leukemia, chronic lymphocytic leukemia, Hodgkin lymphoma, and multiple myeloma each demand distinct therapeutic approaches. Not every hospital tailors protocols to these differences. Key Takeaways Personalized blood cancer treatment requires subtype-specific protocols matched to AML, ALL, CML, lymphoma, or myeloma using advanced diagnostics like immunophenotyping and genetic profiling Hospitals with multidisc

India's blood cancer treatment ecosystem spans government-funded tertiary centers, charitable institutions, and specialized hematology programs—each offering distinct cost structures and advanced therapy access. Patients navigating acute leukemia, lymphoma, or myeloma diagnoses can access chemotherapy, bone marrow transplantation, and emerging CAR-T therapy at costs 70-80% below international benchmarks[9]. Key Takeaways Government hospitals deliver thorough blood cancer trea